bioAffinity Technologies, Inc. Quarterly Cost of Revenue in USD from Q2 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
bioAffinity Technologies, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2022 to Q3 2023.
  • bioAffinity Technologies, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $74.7K, a 51067% increase year-over-year.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $74.7K +$74.6K +51067% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.23K +$1.09K +745% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $87.00 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q3 2022 $146 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $146 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.